A vulnerability chain dubbed AutoJack in Microsoft's AutoGen Studio interface for prototyping AI agents could let attackers ...
Apple’s fall macOS release will let you build Shortcuts by typing what you want to happen. But Claude Code and Codex users ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
He built interfaces that allowed engineers, scientists and everyday people to solve difficult problems without having to ...
To operate safely at higher development velocity, organizations must embed reliability guardrails directly into their ...
Using a strong password is critical to keeping your online accounts secure. However, it isn’t enough on its own in today’s online threat landscape. Even the strongest passwords can fail in the face of ...
With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...